Health
Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis – News-Medical.Net
A new study examines the associations between immunosuppressive disease-modifying therapies (DMTs) used in MS with adverse outcomes in an international cohort of…
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients with coexisting medical conditions have been noted to be at a higher risk of progressive and severe disease. Patients with multiple sclerosis (MS), who are often on immunosuppressive therapy, may be among these high-risk groups.
A new study, released on the medRxiv* preprint server, examines the associations between immunosuppressive disease-modifying…
-
Noosa News9 hours agoExperts share tiny home warning as interest from young people soars
-
General24 hours agoASIC shone a light on private lending and did not like what it saw
-
Noosa News16 hours agoKarenia cristata species source of toxins in SA’s algal bloom, scientists believe
-
General20 hours agoWorld will overshoot 1.5C climate goal, UN report says